Reuters logo
BRIEF-DiaSorin launches Liaison androstenedione test
May 16, 2017 / 8:54 AM / 4 months ago

BRIEF-DiaSorin launches Liaison androstenedione test

May 16 (Reuters) - DIASORIN SPA:

* LAUNCHES NEW LIAISON ANDROSTENEDIONE TEST FOR EVALUATION OF ADRENAL AND GONADAL FUNCTIONALITY

* LIAISON ANDROSTENEDIONE TEST AVAILABLE WORLDWIDE WITH EXCEPTION OF U.S.

* ELEVATED ANDROSTENEDIONE LEVELS IN BLOOD ARE ASSOCIATED WITH HORMONE-RELATED DISEASES SUCH AS POLYCYSTIC OVARIAN SYNDROME (PCOS), CONGENITAL ADRENAL HYPERPLASIA (CAH) AND ADRENAL GLAND TUMORS Source text: reut.rs/2rlnH84 Further company coverage: (Gdynia Newsroom)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below